Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Files to Offer 10.4M Shares

NEW YORK (GenomeWeb News) - Mass spectrometry equipment maker Bruker BioSciences plans to offer for sale a total of 10.4 million shares of the company’s common stock.
The company said Friday that it has filed an S-3 statement with the US Securities and Exchange Commission and plans to offer up 2.2 million shares on its own. Four other shareholders, all members of the Laukien family, will offer an aggregate of 8.2 million shares, Bruker added. Both the company and the shareholders have granted underwriters 30 days to purchase an aggregate of as much as 1.6 million shares for over-allotments.
At midday today Bruker’s shares were trading down 6.5 percent at $7.42.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.